Sponsor or institution

Clinical trials and research at Yuhan Corporation

• 7Clinical trials
• 2New in 30 days
• 6Countries

Newest trials

All recruiting trials (7)

• Bioequivalence comparison between YHP2508B and YHR2602 in healthy adults

  This study tests whether YHP2508B and YHR2602 deliver similar amounts of the drug in healthy adults after a single dose.

  Recruiting Phase 1 Yuhan Corporation · Gimpo-si · NCT07912840

• Bioequivalence test of two drugs in healthy adults

  This study tests whether YHP2508A and YHR2601 are bioequivalent in healthy volunteers.

  Recruiting at 2 sites Phase 1 Yuhan Corporation · Seoul and 1 other locations · NCT07912827

• Lesigercept for adults with chronic spontaneous urticaria not controlled by H1-antihistamines

  This trial tests whether lesigercept, given every four weeks, can reduce symptoms in adults whose chronic spontaneous urticaria is not controlled by second-generation H1-antihistamines.

  Recruiting at 3 sites Phase 2 Yuhan Corporation · Sofia, Sofia and 29 other locations · NCT07415551

• YH32364 for locally advanced or metastatic EGFR‑overexpressing solid tumors

  This trial will test whether YH32364 can help adults with advanced or metastatic cancers that overexpress EGFR when other treatments haven't worked.

  Recruiting at 4 sites Phase 1/2 Yuhan Corporation · Seoul and 3 other locations · NCT06975410

• Evaluating NTCB02-1 for patients needing parenteral nutrition

  This study is testing a new nutritional treatment called NTCB02-1 to see if it helps patients who need feeding through an IV feel better compared to the standard treatment.

  Recruiting at 5 sites Phase 3 Yuhan Corporation · Gyeonggi-do, Goyang-si and 4 other locations · NCT06625957

• Evaluating the safety and effectiveness of YH42946 for advanced solid tumors

  This study is testing a new oral medication called YH42946 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 7 sites Phase 1/2 Yuhan Corporation · Fairfax, Virginia and 7 other locations · NCT06616766

• Treatment with YH32367 for HER2 Positive Advanced Solid Tumors

  This study is testing a new treatment called YH32367 to see if it can safely help people with advanced solid tumors that are HER2-positive.

  Recruiting at 15 sites Phase 1/2 Yuhan Corporation · Boston, Massachusetts and 18 other locations · NCT05523947

Quick answers

How many clinical trials run by Yuhan Corporation are recruiting right now?

7, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in South Korea (7 trials), United States (2 trials), Bulgaria (1 trial), China (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 1: 2, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →